Formulari Ubat KKM (FUKKM)

# Generic Name MDC Category Indications Pres. Restrictions Dosage
1441 Silver Sulfadiazine 1% Cream D06BA01199G1001XX B Prevention and treatment of infections in severe burns, leg ulcers where infections may prevent healing and for the prophylaxis of infections in skin grafting Burns: Apply 3 mm thick layer twice daily with sterile applicator. Leg ulcer: apply at least 3 times a week
1442 Simvastatin 10 mg Tablet C10AA01000T1001XX B i) Hypercholesterolaemia
ii) Prevention of cardiovascular disease		 i) & ii)
10 - 40 mg once daily.
Maximum: 80 mg daily
1443 Simvastatin 20 mg Tablet C10AA01000T1002XX B i) Hypercholesterolaemia
ii) Prevention of cardiovascular disease		 i) & ii)
10 - 40 mg once daily.
Maximum: 80 mg daily
1444 Simvastatin 40 mg Tablet C10AA01000T1003XX B i) Hypercholesterolaemia
ii) Prevention of cardiovascular disease		 i) & ii)
10 - 40 mg once daily.
Maximum: 80 mg daily
1445 Sitagliptin 100 mg Tablet A10BH01000T1003XX A/KK Indicated as adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, as monotherapy when metformin is contraindicated or not tolerated and as add-on therapy to other glucose-lowering agents when adequate glycaemic control is not achieved despite dose optimisation. None ADULT over 18 years, 100 mg once daily
CrCl ≥ 30 to < 50ml/min: 50mg once daily
CrCl < 30 ml/min: 25mg once daily
1446 Sitagliptin 25 mg Tablet A10BH01000T1001XX A/KK Indicated as adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, as monotherapy when metformin is contraindicated or not tolerated and as add-on therapy to other glucose-lowering agents when adequate glycaemic control is not achieved despite dose optimisation. None ADULT over 18 years, 100 mg once daily
CrCl ≥ 30 to < 50ml/min: 50mg once daily
CrCl < 30 ml/min: 25mg once daily
1447 Sitagliptin 50 mg and Metformin HCl 1000 mg Tablet A10BD07926T1003XX A* i) Type 2 diabetes patients, especially the elderly, with multiple co-morbidities that always experience hypoglycaemia with other antidiabetics who are inadequately controlled on metformin or sitagliptin alone or already being treated with the combination of sitagliptin and metformin.
ii) Newly diagnosed type 2 diabetes patients with high baseline HbA1c and multiple co-morbidities who may experience hypoglycaemia with other antidiabetics.		 Consultant/specialists for specific indications only, including Geriatricians
As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea.		 50 mg/500 mg twice daily. The recommended maximum daily dose is 100 mg sitagliptin plus 2000 mg metformin
1448 Sitagliptin 50 mg and Metformin HCl 500 mg Tablet A10BD07926T1001XX A* i)Type 2 diabetes patients, especially the elderly, with multiple co-morbidities that always experience hypoglycaemia with other antidiabetics who are inadequately controlled on metformin or sitagliptin alone or already being treated with the combination of sitagliptin and metformin.
ii)Newly diagnosed type 2 diabetes patients with high baseline HbA1c and multiple co-morbidities who may experience hypoglycaemia with other antidiabetics.		 Consultant/specialists for specific indications only, including Geriatricians
As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea.		 50 mg/500 mg twice daily.
The recommended maximum daily dose is 100 mg sitagliptin plus 2000 mg metformin
1449 Sitagliptin 50 mg and Metformin HCl 850 mg Tablet A10BD07926T1002XX A* i) Type 2 diabetes patients, especially the elderly, with multiple co-morbidities that always experience hypoglycaemia with other antidiabetics who are inadequately controlled on metformin or sitagliptin alone or already being treated with the combination of sitagliptin and metformin.
ii) Newly diagnosed type 2 diabetes patients with high baseline HbA1c and multiple co-morbidities who may experience hypoglycaemia with other antidiabetics.		 Consultant/specialists for specific indications only, including Geriatricians
As add-on therapy for patient who failed therapy and/or contraindicated/unable to tolerate metformin and/or sulphonylurea.		 50 mg/500 mg twice daily.
The recommended maximum daily dose is 100 mg sitagliptin plus 2000 mg metformin
1450 Sitagliptin 50 mg Tablet A10BH01000T1002XX A/KK Indicated as adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus, as monotherapy when metformin is contraindicated or not tolerated and as add-on therapy to other glucose-lowering agents when adequate glycaemic control is not achieved despite dose optimisation. None ADULT over 18 years, 100 mg once daily
CrCl ≥ 30 to < 50ml/min: 50mg once daily
CrCl < 30 ml/min: 25mg once daily
1451 Sodium Acid Phosphate (500mg Phosphorus) Effervescent Tablet B05XA09-902-L50-01-XXX A For supplemental ionic phosphorus for correction of hypophosphataemia According to the needs of the patient
1452 Sodium Alginate 1000 mg/10 ml & Potassium Bicarbonate 200 mg/10 ml Suspension A02BX13-915-L80-01-XXX A* Treatment of symptoms of gastro-oesophageal reflux eg. acid regurgitation, heartburn, indigestion due to the reflux of stomach contents not responding to conventional antacids or as an addition to PPI when PPI alone fails to control the symptoms Adult, elderly & children ≥12 year: 5-10 mL.
1453 Sodium Bicarbonate 1 g/15 ml Mixture A02AH00131L2102XX B i) Relief of discomfort in mild urinary tract ii) Alkalinisation of urine i) 3 g in every 2 hours until urinary pH exceeds 7 ii) Maintenance of alkaline urine 5-10 g daily
1454 Sodium Bicarbonate 8.4% (1 mmol/ml) Injection B05XA02131P3002XX B i) For acceleration of excretion in drug intoxication (where excretion of the drug into the urine is accelerated by elevated urine pH)
ii) For metabolic acidosis secondary to underlying diseases		 According to the needs of the patient.
In severe shock due to cardiac arrest: 50 ml by IV
1455 Sodium Bicarbonate and Magnesium Carbonate Compound Mixture A02AH00912L2101XX C Heartburn, for rapid relief of dyspepsia ADULT 10-20 ml 3 times daily
1456 Sodium Bicarbonate, Citric Acid, Sodium Citrate and Tartaric Acid - 4 g per sachet B05CB10955M4001XX B For relieving of discomfort in mild urinary tract infection, symptomatic relief of dysuria to enchance the action to certain antibiotics especially some sulphonamides. In gout as urinary alkalinizers to prevent cystallisation of urates 4 - 8 g (1- 2 sachets) dissolved in a glass of cold water 4 times daily as prescribed
1457 Sodium Biphosphate 16%, Sodium Phosphate 6% Rectal Solution A06AG01162G2001XX A Bowel cleansing before colonic surgery, colonoscopy or radiological examination to ensure the bowel is free of solid contents. It is not to be used for treatment of constipation ADULT 133 ml (1 bottle) administered rectally.
CHILD more than 2 years half the adult dose (66.6ml)
1458 Sodium Biphosphate 16%, Sodium Phosphate 6% Solution A06AG01162L9901XX A Bowel cleansing before colonic surgery, colonoscopy or radiological examination to ensure the bowel is free of solid contents. It is not to be used for treatment of constipation 45 ml diluted with half a glass (120 mL) of water, followed by one full glass (240 mL) of water. Timing of doses is dependent on the time of the procedure. For morning procedure, first dose should be taken at 7 a.m. and second at 7 p.m. on day before the procedure. For afternoon procedure, first dose should be taken at 7 p.m. on day before and second dose at 7 a.m. on day of the procedure. Solid food should not be taken during the bowel preparation period. However clear fluids or water can be taken liberally. CHILD under 12 years not recommended
1459 Sodium Chloride 0.18% with Dextrose 10% Injection B05XA03904P6001XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1460 Sodium Chloride 0.18% with Dextrose 4.23% Injection B05XA03904P6004XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1461 Sodium Chloride 0.45% Injection B05XA03100P6001XX B For replenishing fluid and for restoring / maintaining the concentration of sodium and chloride ions 100 - 1000 ml by IV or according to the needs of the patient
1462 Sodium Chloride 0.45% with Dextrose 10% Injection B05XA03904P6002XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1463 Sodium Chloride 0.45% with Dextrose 5% Injection B05XA03904P6005XX B For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1464 Sodium Chloride 0.9% Eye Drops S01XA03-000-D20-01-XXX C Irrigation of conjunctival sac None 1 - 2 drops every 3 - 4 hours
1465 Sodium Chloride 0.9% Injection B05XA03100P6002XX C+ For replenishing fluid and for restoring/maintaining the concentration of sodium and chloride ions 100 - 1000 ml by IV or according to the needs of the patient
1466 Sodium Chloride 0.9% with Dextrose 5% Injection B05XA03904P6003XX C+ For replenishing fluid and energy and for restoring or maintaining the concentration of sodium and chloride ions According to the needs of the patient
1467 Sodium Chloride 20% Injection B05XA03100P9902XX B Addition of sodium electrolyte in parenteral nutrition bags especially in paediatrics or neonates with restricted fluid allowance According to the needs of the patient
1468 Sodium Chloride 3% Injection B05XA03100P9901XX B Acute dilutional hyponatraemia According to the needs of the patient
1469 Sodium Chromate (Chromium-51) Solution V09GX00143L9901XX A* Labelling of erythrocytes for the investigation of haemotological disorders Usual dose range : 10 - 200 microcuries IV by IV injection
1470 Sodium Citrate 0.3 M Solution B05CB02136L9901XX B Prophylaxis for aspiration pneumonitis (use as an oral solution) Dose depending on clinical cases. Usually, 30 ml given 10- 60 minutes before anaesthesia prior to elective cesarean surgery is an effective antacid

Halaman-halaman